Showing results (181-190 of 292) with videos related to
Sort By:
Pageof 30
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 18, 2022
Qualitative Analysis of the Design and Implementation of Benefit-Sharing Programs for Biologics Across EuropeTeresa Barcina Lacosta, Arnold G Vulto, Adina Turcu-Stiolica, et al.Frontiers in Medicine|March 31, 2022
Regulatory Information and Guidance on Biosimilars and Their Use Across Europe: A Call for Strengthened One Voice MessagingLiese Barbier, Allary Mbuaki, Steven Simoens, et al.Frontiers in Pharmacology|August 1, 2020
Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?Yujeong Kim, Hye-Young Kwon, Brian Godman, et al.Cardiovascular Drugs and Therapy|September 17, 2008
Atherosclerotic cardiovascular diseases in Belgium: a cost-of-illness analysisJoan Vlayen, Guy De Backer, Jan Peers, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 9, 2015
Chemotherapy drug shortages in paediatric oncology: A 14-year single-centre experience in BelgiumTiene Bauters, Barbara Om Claus, Koen Norga, et al.Frontiers in Pharmacology|June 24, 2017
The Market of Biopharmaceutical Medicines: A Snapshot of a Diverse Industrial LandscapeEvelien Moorkens, Nicolas Meuwissen, Isabelle Huys, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 21, 2025
Toward Regulatory Convergence and Streamlined Biosimilar Development: Recommendations from an International Qualitative StudyElif Car, Liese Barbier, Ingrid Schwarzenberger, et al.Frontiers in Pharmacology|October 16, 2023
Not one, but many: developing a multi-indication pricing model for medicines in BelgiumIngrid Maes, Eline Kok, Pieter-Jan De Torck, et al.European Journal of Public Health|December 5, 2021
Cost-effectiveness of exercise referral schemes: a systematic review of health economic studiesAmber Werbrouck, Masja Schmidt, Koen Putman, et al.Frontiers in Pharmacology|January 24, 2022
Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory CareYannick Vandenplas, Liese Barbier, Steven Simoens, et al.Pageof 30